Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

LEGGE, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 434
EU - Europa 97
NA - Nord America 50
AF - Africa 1
Totale 582
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 429
DE - Germania 71
US - Stati Uniti d'America 50
CZ - Repubblica Ceca 9
IT - Italia 9
UA - Ucraina 3
CN - Cina 2
FI - Finlandia 2
HR - Croazia 2
EG - Egitto 1
HK - Hong Kong 1
ID - Indonesia 1
NL - Olanda 1
TR - Turchia 1
Totale 582
Salva come PNG Salva come JPEG
Città #
Singapore 200
Munich 65
Atlanta 10
Brno 9
The Dalles 8
Bari 3
Clifton 3
Denver 2
Milan 2
Phoenix 2
Rome 2
Santa Clara 2
Tappahannock 2
Zagreb 2
Angri 1
Ankara 1
Changsha 1
Espoo 1
Fisciano 1
Helsinki 1
Hong Kong 1
Ismailia 1
Totale 320
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent endometrial cancer: analysis of post-relapse survival by pattern of recurrence and secondary treatment 11
Cyclooxygenase-2 (COX-2) inhibition is associated with increased proportion of Tumor Infiltrating Lymphocytes (TIL) expressing the zeta chain of T-Cell Receptor (TCR) in human cervical cancer 11
Celecoxib plus carboplatin in heavily pre-treated patients with recurrent ovarian carcinoma: preliminary results of a phase II study 10
Whose surgery is this? Endometriosis of the round ligament 9
Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: Clinical considerations 9
Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score Analysis 9
Tumori maligni della cervice uterina 9
Comparison of absorbable and permanent sutures for laparoscopic sacrocervicopexy: A randomized controlled trial 9
Advances in surgical management of cervical cancer 9
Ruolo dell'isterectomia laparoscopica nel trattamento del carcinoma della cervice uterina 8
Celecoxib modulates the expression of cyclooxygenase-2, Ki67, apoptosis-related marker, and microvessel density in human cervical cancer: A pilot study 8
Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters 8
Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions 8
Targeted therapies in gynecological cancers 8
Il carcinoma ovarico familiare 8
Prognostic role of the ratio between cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer 8
Celecoxib modulates angiogenesis-related parameters in both sera and tumor biopsies from cervical cancer patients 7
Tumori maligni della cervice uterina 7
Targeted therapy for ovarian cancer 7
Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer 7
Tamoxifen modulates the expression of Ki67, apoptosis, and microvessel density in cervical cancer 7
Fattori prognostici nel carcinoma ovarico epiteliale 7
Prospettive future per i tumori della cervice uterina 7
Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study 7
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 7
Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: Safety, outcome, and prognostic measures 7
Fertility-Sparing Surgery in Ovarian Cancer Extended beyond the Ovaries: A Case Report and Review of the Literature 7
Pseudo-Meigs' syndrome associated with malignant struma ovarii: a case report 7
Cyclooxygenase-2 expression in borderline ovarian tumors 7
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study 7
Laparoscopic vs transvaginal cuff closure after total laparoscopic hysterectomy: a randomized trial by the Italian Society of Gynecologic Endoscopy 7
Nerve-sparing laparoscopic colposacropexy using a percutaneous surgical system: a case report 6
Biologia e genetica molecolare in ginecologia ed ostetricia 6
Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept 6
Laparoscopic versus robotic hysterectomy in obese and extremely obese patients with endometrial cancer: A multi-institutional analysis 6
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge 6
Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients 6
Magnetic resonance imaging of pelvic endometriosis. Effect of reader's experience on accuracy and interobserver variability 6
Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing Preoperative radiochemotherapy: Association with pathological response to treatment and clinical outcome 6
Tumori dell'ovaio 6
Phase II study on Pemetrexed in advanced and/or recurrent cervical cancer patients: a MITO study 6
Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinicopathological parameters 6
Prognostic factors in clear cell carcinoma of endometrium: analysis of 55 cases 6
Biological characterization of ovarian cancer: prognostic and therapeutic implications 6
BRCA1-related malignancies in a family presenting with von Recklinghausen's disease 6
Which role for pre-treatment laparoscopic staging? 6
Comparison Between Laparoscopic and Robotic Surgery in Elderly Patients With Endometrial Cancer: A Retrospective Multicentric Study 6
Proposal of a prognostic score in combined modality treatment of locally advanced carcinoma of the uterine cervix 6
Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients 6
Novel VEGF-independent Strategies Targeting Tumor Vasculature: Clinical Aspects 6
[Familial ovarian carcinoma] 6
Laparoscopic radical hysterectomy in cervical cancer as “Total MesoMetrial Resection (L-TMMR)”: a multicentric experience 6
Participation of patients with gynecological cancer in phase I clinical trials: Two years experience in a major cancer center 6
Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosis 6
Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome 6
Robotic Surgery in Elderly and Very Elderly Gynecologic Cancer Patients 6
Prolonged Chemoradiation in Locally Advanced Carcinoma of the Uterine Cervix Final Results of a Phase II Study (ESTER-1) 6
Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients 6
Intensified pre-operative chemoradiation in locally advanced carcinoma of the uterine cervix: final resultsof a phase I-II study (ESTER-1) 5
Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications 5
Carboplatin (C) plus paclitaxel (P) versus carboplatin plus pegylated liposomal doxorubicin (PLD) in patients with advanced ovarian cancer (AOC): final analysis of the MITO-2 randomized multicenter trial 5
Cyclooxygenase-2 expression in endometrial carcinoma - Correlation with clinicopathologic parameters and clinical outcome 5
Angiogenesis inhibitors in gynecological cancers 5
New drugs in ovarian cancer 5
Postoperative concomitant boost radiotherapy in high risk endometrial cancer 5
Il tumore ovarico borderline: diagnosi, trattamento, restaging 5
Risk Assessment Model for Complications in Minimally Invasive Hysterectomy: A Pilot Study 5
Laparoscopic en bloc right diaphragmatic peritonectomy for diaphragmatic endometriosis according to the Sugarbaker technique 5
Transplacental carcinogenesis: state of the art 5
Verso la classificazione molecolare dei tumori: possibili implicazioni prognostiche e terapeutiche 5
Intensity-modulated extended field chemoradiation plus simultaneous integrated boost in the preoperative treatment of locally advanced cervical cancer: a dose-escalation study 5
Prognostic role of the ratio between cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer 5
Endometriosis and Cancer 5
Comparison of Different Surgical Approaches for Stage IB1 Cervical Cancer Patients: A Multi-institution Study and a Review of the Literature 5
Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancer 5
Progestin-realising intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 5
Risk factors for ovarian cancer in central Italy 5
Analysis of survivin expression in ovarian cancer and its correlation with clinical, surgical, pathological and apoptosis-related parameters 5
[Biological factors with prognostic significance in ovarian cancer]. Fattori biologici con significato prognostico nel cancro ovarico 5
A prospective multicentric study of risk-reducing salpingo-oophorectomy in BRCA mutation patients 5
From bio-molecular and technology innovations to clinical practice: focus on ovarian cancer 5
Large-field pre-operative chemoradiation in locally advanced carcinoma of the cervix: preliminary results of a phase I study (LARA-CC-1) 5
Cyclooxygenase-2 (COX-2) expression in non neoplastic (NNED) and  neoplastic vulvar epithelial disorders 5
Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients 5
Radical surgery (RS) plus intraperitoneal hyperthermic perfusion (IPHP) with oxaliplatin followed by intravenous docetaxel in the treatment of peritoneal carcinosis from platinum-sensitive recurrent ovarian cancer (OC): A pilot study 5
Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancer 5
Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, modulates cytokines levels in serum of cervical cancer patients 5
Locally advanced cervical carcinoma patients treated with chemoradiation followed by radical surgery: clinical response and oncological outcomes according to histotype after propensity score analysis Eur J Surg Oncol 5
Sexual function after laparoscopic vs. transvaginal closure of the vaginal vault after laparoscopic hysterectomy: a secondary analysis of a randomized trial by the Italian Society of Gynecological Endoscopy, using a validated questionnaire 5
New insights in biological characterization of ovarian cancer 5
Indicatori molecolari prognostici e predittivi di risposta nel carcinoma ovarico 5
Anatomical distribution of sentinel lymph nodes in patients with endometrial cancer: a multicenter study 5
Biologia e genetica molecolare in ginecologia ed ostetricia 5
Simultaneous integrated boost volumetric modulated Arc therapy in the postoperative treatment of high-risk to intermediate-risk endometrial cancer: results of ADA II phase I-II trial 5
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients. 5
The peritoneal cavity: tumor metastasis and growth 5
Lymphocyte populations in human lymph nodes. Alterations in CD4(+) CD25(+) T regulatory cell phenotype and T-cell receptor V beta repertoire 5
Laparoscopic sacrocolpopexy versus pelvic organ prolapse suspension for surgical management of pelvic organ prolapse: a retrospective study 5
Celecoxib up-regulates the expression of the zeta chain of T cell receptor complex in tumor-infiltrating lymphocytes in human cervical cancer 5
Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B 5
Totale 619
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.332
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.332
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024203 0 0 0 121 9 2 0 1 24 30 4 12
2024/2025500 19 48 40 24 74 2 1 24 193 13 62 0
Totale 703